Volume 12, Number 8—August 2006
Dispatch
Human and Canine Pulmonary Blastomycosis, North Carolina, 2001–2002
Table 1
Feature | Value |
---|---|
Median age, y (range) | 25 (15–82) |
Race, no. (%) | |
African American | 5 (63) |
White | 3 (37) |
Sex, no. (%) | |
Male | 6 (75) |
Clinical signs and symptoms, no. (%) | |
Cough | 5 (71) |
Fever | 6 (86) |
Chest pain | 6 (86) |
Shortness of breath | 4 (57) |
Clinical outcomes, no. (%) | |
Hospitalized | 8 (100) |
Pneumonia diagnosed | 8 (100) |
Failed antimicrobial drug treatment | 8 (100) |
Treated with itraconazole* | 6 (75) |
Survived | 7 (87) |
*One patient with multiple underlying medical problems was treated with amphotericin B; another patient was treated with fluconazole.
1Current affiliation: University of North Carolina
Page created: December 09, 2011
Page updated: December 09, 2011
Page reviewed: December 09, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.